Marshall Wace, LLP Gossamer Bio, Inc. Transaction History

Marshall Wace, LLP

$74.4 Billion
Q1 2025

A detailed history of Marshall Wace, LLP transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 1,713,655 shares of GOSS stock, worth $3.15 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,713,655

Previous 2,534,378 32.38%

Holding current value

$3.15 Million

Previous $2.28 Million 17.32%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$0.85 - $1.53 $697,614 - $1.26 Million	-820,723 Reduced 32.38%	1,713,655 $1.89 Million
Q4 2024 Feb 13, 2025	SELL	$0.66 - $1.07 $627,365 - $1.02 Million	-950,554 Reduced 27.28%	2,534,378 $2.28 Million
Q3 2024 Nov 14, 2024	BUY	$0.79 - $1.25 $118,042 - $186,776	149,421 Added 4.48%	3,484,932 $3.45 Million
Q2 2024 Aug 14, 2024	BUY	$0.51 - $1.27 $1.07 Million - $2.67 Million	2,103,766 Added 170.8%	3,335,511 $3 Million
Q1 2024 May 15, 2024	BUY	$0.8 - $1.51 $172,769 - $326,102	215,962 Added 21.26%	1,231,745 $1.45 Million
Q4 2023 Feb 14, 2024	SELL	$0.48 - $1.08 $302,895 - $681,514	-631,032 Reduced 38.32%	1,015,783 $924,000
Q3 2023 Nov 14, 2023	SELL	$0.78 - $1.82 $81,354 - $189,826	-104,300 Reduced 5.96%	1,646,815 $1.37 Million
Q2 2023 Aug 14, 2023	SELL	$0.98 - $1.53 $18,912 - $29,525	-19,298 Reduced 1.09%	1,751,115 $2.1 Million
Q1 2023 May 15, 2023	BUY	$0.96 - $2.92 $724,764 - $2.2 Million	754,963 Added 74.35%	1,770,413 $2.23 Million
Q4 2022 Feb 14, 2023	BUY	$1.74 - $12.87 $897,655 - $6.64 Million	515,894 Added 103.27%	1,015,450 $2.2 Million
Q3 2022 Nov 14, 2022	BUY	$7.21 - $14.88 $1.09 Million - $2.26 Million	151,805 Added 43.65%	499,556 $5.99 Million
Q2 2022 Aug 15, 2022	SELL	$5.97 - $9.97 $1.34 Million - $2.24 Million	-224,321 Reduced 39.21%	347,751 $2.91 Million
Q4 2021 Feb 14, 2022	BUY	$10.12 - $14.07 $5.59 Million - $7.78 Million	552,820 Added 2871.49%	572,072 $6.47 Million
Q1 2021 May 17, 2021	SELL	$8.63 - $10.94 $107,219 - $135,918	-12,424 Reduced 39.22%	19,252 $178,000
Q4 2020 Feb 16, 2021	SELL	$8.3 - $13.59 $55,468 - $90,821	-6,683 Reduced 17.42%	31,676 $306,000
Q3 2020 Nov 16, 2020	BUY	$11.3 - $14.75 $433,456 - $565,795	38,359 New	38,359 $476,000

Others Institutions Holding GOSS

# of Institutions

125

Shares Held

161M

Call Options Held

2.11M

Put Options Held

57.8K

View Full List

About Gossamer Bio, Inc.

Ticker GOSS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,954,000
Market Cap $173M
Description
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...

More about GOSS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Account

Marshall Wace, LLP Gossamer Bio, Inc. Transaction History